![Reza Mazhari](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Reza Mazhari
Profile
Reza Mazhari is the founder of Cardioxyl Pharmaceuticals LLC, which was founded in 2005.
He held the title of Vice President-Research & Pharmacology in 2010.
Dr. Mazhari also worked as a Director-Cardiovascular Physiology at Artesian Therapeutics, Inc. and as a Professor at The Johns Hopkins University.
Dr. Mazhari received his undergraduate and doctorate degrees from the University of California, Berkeley.
Former positions of Reza Mazhari
Companies | Position | End |
---|---|---|
Artesian Therapeutics, Inc.
![]() Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Corporate Officer/Principal | - |
The Johns Hopkins University | Corporate Officer/Principal | - |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Founder | - |
Training of Reza Mazhari
University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Artesian Therapeutics, Inc.
![]() Artesian Therapeutics, Inc. BiotechnologyHealth Technology Artesian Therapeutics, Inc. develops and manufactures biopharmaceutical therapeutic products. Its products are used for the treatment of cardiovascular and other life threat diseases. The company was founded by Peter D. Suzdak in March 2002 and is located in Gaithersburg, MD | Health Technology |
- Stock Market
- Insiders
- Reza Mazhari